Out-of-pocket spending on insulin among people with private insurance

(By Krutika Amin, Gary Claxton, Matthew Rae, and Cynthia Cox for Kaiser Family Foundation published March 24, 2022)

The Build Back Better Act, which has passed the House but stalled in the Senate, would cap insulin out-of-pocket costs for people with insurance. Several other recent legislative proposals would also limit out-of-pocket spending on insulin, including the Ending Pricey Insulin Act, introduced in April 2021 by Senator John Kennedy and the Affordable Insulin Now Act, introduced in February 2022 by Senator Reverend Raphael Warnock. Recently, on March 22, 2022, Senate Majority Leader Chuck Schumer indicated that bipartisan talks are underway led by Senator Susan Collins and Senator Jeanne Shaheen to combine Senator Warnock’s bill to cap insulin out-of-pocket costs with policies to lower insulin list prices. A 2019 bill introduced by Senator Jeanne Shaheen and co-sponsored by Senator Susan Collins, the Insulin Price Reduction Act, proposed to limit insulin price growth. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org